Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason A Roy

Showing results (41-50 of 63) with videos related to

Pageof 7
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 7, 2021
Respiratory Microbiome Disruption and Risk for Ventilator-Associated Lower Respiratory Tract InfectionJames J Harrigan, Hatem O Abdallah, Erik L Clarke, et al.
American Journal of Respiratory and Critical Care Medicine|March 4, 2015
Global epidemiology of pediatric severe sepsis: the sepsis prevalence, outcomes, and therapies studyScott L Weiss, Julie C Fitzgerald, John Pappachan, et al.
Pharmacoepidemiology and Drug Safety|July 20, 2017
Risk of liver decompensation with cumulative use of mitochondrial toxic nucleoside analogues in HIV/hepatitis C virus coinfectionVincent Lo Re, Bret Zeldow, Michael J Kallan, et al.
Pharmacoepidemiology and Drug Safety|July 28, 2015
Use of demographic and pharmacy data to identify patients included within both the Clinical Practice Research Datalink (CPRD) and The Health Improvement Network (THIN)Dena M Carbonari, M Elle Saine, Craig W Newcomb, et al.
Inflammatory Bowel Diseases|December 12, 2018
Improved Quality of Life With Anti-TNF Therapy Compared With Continued Corticosteroid Utilization in Crohn's DiseaseFrank I Scott, F Reed Johnson, Meenakshi Bewtra, et al.
Critical Care (London, England)|September 17, 2015
Discordant identification of pediatric severe sepsis by research and clinical definitions in the SPROUT international point prevalence studyScott L Weiss, Julie C Fitzgerald, Frank A Maffei, et al.
The Lancet. Primary Care|December 19, 2025
Prescription opioid use and opioid use disorder among older adults with HIV in the USA from 2008 to 2021: a retrospective repeated cross-sectional studyStephanie Shiau, Fabrizio Drago, Carolyn W Kinkade, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 12, 2016
Disparities in Absolute Denial of Modern Hepatitis C Therapy by Type of InsuranceVincent Lo Re, Charitha Gowda, Paul N Urick, et al.
The American Journal of Medicine|November 25, 2015
Oral Azole Antifungal Medications and Risk of Acute Liver Injury, Overall and by Chronic Liver Disease StatusVincent Lo Re, Dean M Carbonari, James D Lewis, et al.
BMC Pharmacology & Toxicology|April 19, 2015
Determinants of saxagliptin use among patients with type 2 diabetes mellitus treated with oral anti-diabetic drugsM Elle Saine, Dena M Carbonari, Craig W Newcomb, et al.
Pageof 7

Showing results (41-50 of 63) with videos related to

Sort By:
Pageof 7
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 7, 2021
Respiratory Microbiome Disruption and Risk for Ventilator-Associated Lower Respiratory Tract InfectionJames J Harrigan, Hatem O Abdallah, Erik L Clarke, et al.
American Journal of Respiratory and Critical Care Medicine|March 4, 2015
Global epidemiology of pediatric severe sepsis: the sepsis prevalence, outcomes, and therapies studyScott L Weiss, Julie C Fitzgerald, John Pappachan, et al.
Pharmacoepidemiology and Drug Safety|July 20, 2017
Risk of liver decompensation with cumulative use of mitochondrial toxic nucleoside analogues in HIV/hepatitis C virus coinfectionVincent Lo Re, Bret Zeldow, Michael J Kallan, et al.
Pharmacoepidemiology and Drug Safety|July 28, 2015
Use of demographic and pharmacy data to identify patients included within both the Clinical Practice Research Datalink (CPRD) and The Health Improvement Network (THIN)Dena M Carbonari, M Elle Saine, Craig W Newcomb, et al.
Inflammatory Bowel Diseases|December 12, 2018
Improved Quality of Life With Anti-TNF Therapy Compared With Continued Corticosteroid Utilization in Crohn's DiseaseFrank I Scott, F Reed Johnson, Meenakshi Bewtra, et al.
Critical Care (London, England)|September 17, 2015
Discordant identification of pediatric severe sepsis by research and clinical definitions in the SPROUT international point prevalence studyScott L Weiss, Julie C Fitzgerald, Frank A Maffei, et al.
The Lancet. Primary Care|December 19, 2025
Prescription opioid use and opioid use disorder among older adults with HIV in the USA from 2008 to 2021: a retrospective repeated cross-sectional studyStephanie Shiau, Fabrizio Drago, Carolyn W Kinkade, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 12, 2016
Disparities in Absolute Denial of Modern Hepatitis C Therapy by Type of InsuranceVincent Lo Re, Charitha Gowda, Paul N Urick, et al.
The American Journal of Medicine|November 25, 2015
Oral Azole Antifungal Medications and Risk of Acute Liver Injury, Overall and by Chronic Liver Disease StatusVincent Lo Re, Dean M Carbonari, James D Lewis, et al.
BMC Pharmacology & Toxicology|April 19, 2015
Determinants of saxagliptin use among patients with type 2 diabetes mellitus treated with oral anti-diabetic drugsM Elle Saine, Dena M Carbonari, Craig W Newcomb, et al.
Pageof 7